Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05563558 |
Title | Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) (PEAPOD_FOS) |
Acronym | PEAPOD_FOS |
Recruitment | Recruiting |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Fundacion Oncosur |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ESP |